Alkion Biopharma SAS

Alkion Biopharma SAS is a company in Evry, France that has taken part in 2 EU-funded projects since 2013, receiving €651k in EU funding.

EU funding received€651k
EU projects2
As coordinator0
Running now0
First EU project2013
Latest project2014
CountryFrance
EU registration (PIC)954837737
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Alkion Biopharma SAS's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€651k · 2 projects

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • DRUGTISSUECULTPartner

    Plant Tissue Cultures as New Production Platforms for Terpenoid Based Anti-Cancer Drugs

    FP7 (2007 to 2013) · 2014–2018 · Project on CORDIS ↗

  • TriForCPartner

    A pipeline for the discovery, sustainable production and commercial utilisation of known and novel high-value triterpenes with new or superior biological activities

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €651ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • biochemistry
  • bioreactors
  • ecosystems
  • environmental sciences
  • metabolic engineering
  • oncology
  • pharmaceutical drugs
  • sustainable economy

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime